Successfully treating chronic pain is challenging, as patients respond heterogeneously to analgesic treatments. Such variation in response can be attributed to differing underlying pain-generating mechanisms. A novel clinical bedside test that identifies distinct pain phenotypes might help deliver more-effective mechanism-based treatment strategies.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Scholz, J. et al. A novel tool for the assessment of pain: validation in low back pain. PLoS Med. 6, e1000047 (2009).
Baron, R. Mechanisms of disease: neuropathic pain—a clinical perspective. Nat. Clin. Pract. Neurol. 2, 95–106 (2006).
Woolf, C. J. et al. Towards a mechanism-based classification of pain? Pain 77, 227–229 (1998).
Rolke, R. et al. Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): standardized protocol and reference values. Pain 123, 231–243 (2006).
Bouhassira, D. et al. Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain 114, 29–36 (2005).
Freynhagen, R., Baron, R., Gockel, U. & Tölle, T. R. painDETECT: a new screening questionnaire to identify neuropathic components in patients with back pain. Curr. Med. Res. Opin. 22, 1911–1920 (2006).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
G. Wasner has acted as a consultant for Amgen and has received honoraria for speaking from Grünenthal, Medtronic, Mundipharma, and Pfizer Pharma. R. Baron has acted as a consultant or on the speaker's bureau for Allergan, Eisai, Genzyme, Grünenthal, Medtronic, Mundipharma, Pfizer Pharma, Sanofi Pasteur, and Schwarz. He has also received grants or research support from Genzyme, Grünenthal, and Pfizer Pharma.
Rights and permissions
About this article
Cite this article
Wasner, G., Baron, R. Clinical pain assessment: from bedside to better treatment. Nat Rev Neurol 5, 359–361 (2009). https://doi.org/10.1038/nrneurol.2009.93
Issue Date:
DOI: https://doi.org/10.1038/nrneurol.2009.93